VANOLI, FIAMMETTA
 Distribuzione geografica
Continente #
NA - Nord America 753
EU - Europa 304
AS - Asia 84
AF - Africa 15
SA - Sud America 5
Totale 1.161
Nazione #
US - Stati Uniti d'America 741
IT - Italia 176
IN - India 47
SE - Svezia 39
FR - Francia 13
JP - Giappone 13
TG - Togo 11
CN - Cina 10
DE - Germania 10
CA - Canada 9
GB - Regno Unito 9
BG - Bulgaria 6
ES - Italia 6
FI - Finlandia 6
IE - Irlanda 6
SG - Singapore 6
RS - Serbia 5
UA - Ucraina 5
CH - Svizzera 4
AL - Albania 3
MX - Messico 3
RO - Romania 3
VN - Vietnam 3
AR - Argentina 2
BE - Belgio 2
BR - Brasile 2
CZ - Repubblica Ceca 2
IS - Islanda 2
MA - Marocco 2
NL - Olanda 2
PL - Polonia 2
SC - Seychelles 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
CO - Colombia 1
EE - Estonia 1
HR - Croazia 1
HU - Ungheria 1
ID - Indonesia 1
SA - Arabia Saudita 1
Totale 1.161
Città #
Fairfield 119
Chandler 94
Ashburn 68
Woodbridge 43
Cambridge 41
Houston 38
Rome 37
Wilmington 36
Milan 32
Seattle 32
Princeton 25
New York 22
San Paolo di Civitate 18
Lawrence 16
Dearborn 13
San Diego 13
Lomé 11
Ann Arbor 10
Millbury 10
Boston 9
Bengaluru 7
Ponzano Veneto 7
Andover 6
Chicago 6
Dublin 6
Fasano 6
Helsinki 6
Naples 6
Plano 6
Sofia 6
Fremont 5
Nanjing 4
Norwalk 4
Toronto 4
Zurich 4
Bari 3
Bremen 3
Cascina 3
Kyoto 3
Madrid 3
Tirana 3
Tokyo 3
Barcelona 2
Bien Hoa 2
Brussels 2
Bühl 2
Federal 2
Genoa 2
Heiseicho 2
Istanbul 2
Keflavik 2
La Spezia 2
London 2
Manchester 2
Nis 2
Ottawa 2
Oulad Teima 2
Pardubice 2
Pavia 2
Phoenix 2
Pisa 2
Saint-Augustin-de-Desmaures 2
San Mateo 2
Sapporo 2
Stara Pazova 2
Torre Del Greco 2
Turin 2
Verona 2
Vitória da Conquista 2
Amsterdam 1
Annapolis 1
Aprilia 1
Atlanta 1
Belgrade 1
Boardman 1
Bolsena 1
Brescia 1
Budapest 1
Canfield 1
Chennai 1
Chieti 1
Cori 1
Dallas 1
Dubai 1
Edinburgh 1
Florence 1
Formello 1
Frankfurt am Main 1
Greensburg 1
Guangzhou 1
Gurgaon 1
Hanoi 1
Hounslow 1
Jakarta 1
Jamundí 1
Mahé 1
Matera 1
Mexico City 1
Miami 1
Montreal 1
Totale 876
Nome #
Safety, efficacy, and tolerability of efgartigimod in patients with generalised myasthenia gravis (ADAPT). a multicentre, randomised, placebo-controlled, phase 3 trial 124
miRNA in spinal muscular atrophy pathogenesis and therapy 87
Nerve high-resolution ultrasonography in peripheral nerve injuries associated with supracondylar humeral fractures in children 85
A 34-year longitudinal study on long-term cardiac outcomes in DM1 patients with normal ECG at baseline at an Italian clinical centre 80
Widening the phenotypical spectrum of EGR2-related CMT: unusual phenotype for R409W mutation 80
Nerve high resolution ultrasonography in Tangier disease 79
Multifocal motor neuropathy following treatment with adalimumab for ulcerative colitis 74
Changes of clinical, neurophysiological and nerve ultrasound characteristics in CIDP over time: a 3-year follow-up 67
Muscle involvement in myasthenia gravis: Expanding the clinical spectrum of Myasthenia-Myositis association from a large cohort of patients 62
Clinical and molecular features and therapeutic perspectives of spinal muscular atrophy with respiratory distress type 1 58
Gender effect on cardiac involvement in myotonic dystrophy type 1 52
Skin biopsy and quantitative sensory assessment in an Italian cohort of ATTRv patients with polyneuropathy and asymptomatic carriers: possible evidence of early non-length dependent denervation 50
Novel ACTA1 mutation causes late-presenting nemaline myopathy with unusual dark cores 48
ATTRv amyloidosis Italian Registry: clinical and epidemiological data 47
Nerve ultrasonography findings as possible pitfall in differential diagnosis between hereditary transthyretin amyloidosis with polyneuropathy and chronic inflammatory demyelinating polyneuropathy 36
Muscle MRI in immune-mediated necrotizing myopathy (IMNM). implications for clinical management and treatment strategies 33
High-resolution ultrasound of peripheral nerves in late-onset hereditary transthyretin amyloidosis with polyneuropathy: similarities and differences with CIDP 32
Complement Inhibition for the Treatment of Myasthenia Gravis 32
Anti-Spike IgG in multiple sclerosis patients after BNT162b2 vaccine: An exploratory case-control study in Italy 28
Comparison of quantitative muscle ultrasound and whole-body muscle MRI in facioscapulohumeral muscular dystrophy type 1 patients 24
Iatrogenic Kaposi’s sarcoma in myasthenia gravis: learnings from two case reports 18
Antibody Therapies in Autoimmune Neuromuscular Junction Disorders: Approach to Myasthenic Crisis and Chronic Management 17
Development and validation of the Myasthenia Gravis TeleScore (MGTS) 13
Nerve high-resolution ultrasound in a 2-years follow-up of radial nerve palsy related to humeral shaft fractures 12
What are the pharmacotherapeutic considerations for the treatment of myasthenia gravis? 9
Ravulizumab for the treatment of myasthenia gravis. 6
null 4
null 1
Totale 1.258
Categoria #
all - tutte 3.960
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.960


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201964 0 0 0 0 0 0 0 0 0 12 28 24
2019/2020176 14 5 1 12 24 32 24 21 18 9 7 9
2020/2021134 8 7 5 16 5 9 39 3 8 20 2 12
2021/2022276 39 9 15 14 33 18 12 17 31 8 50 30
2022/2023398 51 60 12 50 44 47 33 23 27 6 33 12
2023/2024183 15 22 15 11 18 41 10 13 4 34 0 0
Totale 1.258